<DOC>
	<DOC>NCT00758407</DOC>
	<brief_summary>The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.</brief_summary>
	<brief_title>Methylphenidate Treatment of Cancer-Related Fatigue</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>history of Cancer MFI &gt;40 Karnofsky Index &gt;=70 outpatient patient are able to give informed consent treatment with psychostimulants in the past two weeks before screening active tumor disease depression (HADS &gt;10) cachexia (BMI &lt;18kg/m2) clinically relevant kidney disorders clinically relevant liver disorder pathological ECGfinding high blood pressure occlusive arterial disease angina pectoris cardiac arrhythmias CHD post heartattack status post stroke status known elevated intraocular pressure known enlarged prostates latent and manifest hyperthyreosis alcohol, medication or drug dependency in the past six months or manifest drug abuse participation in a clinical study within the past 30 days participation in this study at an earlier point in time simultaneous participation in another clinical trial women of childbearing age without adequate contraception (contraceptives, intrauterine device , no sexual intercourse) pregnancy (positive pregnancy test) or lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Fatigue, Cancer, Methylphenidate,</keyword>
</DOC>